MDGLMadrigal Pharmaceuticals, Inc.
$471.93+7.3% 1Y
$471.93
$412.3552 weeks$602.83
Is the price fair?
What MDGL's price assumes
Madrigal Pharmaceuticals, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 9.23× revenue.
9.23
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 22.6
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 8.84
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 22.6
- EV / EBIToperating margin −25%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 8.84
- Market capitalisation
- $11.8B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.